ATE478964T1 - Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde - Google Patents

Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Info

Publication number
ATE478964T1
ATE478964T1 AT05745933T AT05745933T ATE478964T1 AT E478964 T1 ATE478964 T1 AT E478964T1 AT 05745933 T AT05745933 T AT 05745933T AT 05745933 T AT05745933 T AT 05745933T AT E478964 T1 ATE478964 T1 AT E478964T1
Authority
AT
Austria
Prior art keywords
probe
screening
diagnosing
nucleic acid
marfan syndrome
Prior art date
Application number
AT05745933T
Other languages
English (en)
Inventor
Norio Niikawa
Naomichi Matsumoto
Catherine Boileau
Gwenaielle Beroud
Guillaume Jondeau
Original Assignee
Univ Nagasaki
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nagasaki, Inst Nat Sante Rech Med filed Critical Univ Nagasaki
Application granted granted Critical
Publication of ATE478964T1 publication Critical patent/ATE478964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Techniques For Improving Reliability Of Storages (AREA)
  • Testing Of Individual Semiconductor Devices (AREA)
AT05745933T 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde ATE478964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004158099A JP4706193B2 (ja) 2004-05-27 2004-05-27 マルファン症候群の分析のためのプローブの使用、スクリーニング方法およびキット
PCT/JP2005/010213 WO2005116253A1 (ja) 2004-05-27 2005-05-27 マルファン症候群診断用プローブ、及び当該プローブを用いたスクリーニング法

Publications (1)

Publication Number Publication Date
ATE478964T1 true ATE478964T1 (de) 2010-09-15

Family

ID=35450905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05745933T ATE478964T1 (de) 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Country Status (6)

Country Link
US (2) US20080199856A1 (de)
EP (1) EP1767653B1 (de)
JP (1) JP4706193B2 (de)
AT (1) ATE478964T1 (de)
DE (1) DE602005023160D1 (de)
WO (1) WO2005116253A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11692028B2 (en) 2017-03-02 2023-07-04 The Johns Hopkins University Map kinase pathway targets for the treatment of Marfan syndrome
WO2019113123A1 (en) * 2017-12-04 2019-06-13 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
CN109666676A (zh) * 2019-01-29 2019-04-23 四川省人民医院 筛查马凡综合征的试剂盒
CN109666678A (zh) * 2019-01-29 2019-04-23 四川省人民医院 检测马凡综合征的试剂盒
CN109666729A (zh) * 2019-01-29 2019-04-23 四川省人民医院 一种马凡综合征筛查试剂盒
CN114214398B (zh) * 2021-09-26 2022-10-25 百世诺(北京)医学检验实验室有限公司 突变的fbn1基因及马凡氏综合征检测试剂盒
CN114107452B (zh) * 2021-12-07 2022-06-24 深圳市眼科医院 一种基于fbn1基因插入突变的马凡综合征检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4124815B2 (ja) * 1991-10-31 2008-07-23 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ ＴＧＦ−β型受容体ｃＤＮＡおよびその用途
US6008011A (en) * 1991-10-31 1999-12-28 Whitehead Institute For Biomedical Research TGF-β type II receptor cDNAs

Also Published As

Publication number Publication date
EP1767653A1 (de) 2007-03-28
DE602005023160D1 (de) 2010-10-07
EP1767653B1 (de) 2010-08-25
EP1767653A4 (de) 2008-04-16
JP4706193B2 (ja) 2011-06-22
US20100209923A1 (en) 2010-08-19
US20080199856A1 (en) 2008-08-21
WO2005116253A1 (ja) 2005-12-08
JP2005333896A (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
ATE545712T1 (de) Verfahren mit verwendung von poren
ATE550099T1 (de) Verbessertes system für mehrfarbige echtzeit-pcr
ATE488251T1 (de) Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602006010764D1 (de) Modifikatoren der Lichtemission und ihre Verwendungen zur Detektion, Amplifikation und Analyse von Nukleinsäuren
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
NO20070521L (no) Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40
ATE478964T1 (de) Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde
ATE545030T1 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
DE60326153D1 (de) Verfahren zur diagnose von morbus alzheimer
ATE529508T1 (de) Verfahren zum nachweis von latentem hopfenvirus, primersatz für den nachweis und kit für den nachweis
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
DE60041582D1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
DE60322529D1 (de) Verfahren zur verhinderung von fouling in basischer lösung durch inhibierung der polymerisation und solubilisierung von ablagerungen unter verwendung von lactamen oder aminosäuren
ATE335853T1 (de) Verfahren zum nachweis von hybridisierungsereignissen in nukleinsäuren
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE432996T1 (de) Verfahren zur bestimmung des bodenzustands

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties